Florida Senate - 2023 COMMITTEE AMENDMENT Bill No. SB 1550 Ì297190/Î297190 LEGISLATIVE ACTION Senate . House Comm: RCS . 03/28/2023 . . . . ————————————————————————————————————————————————————————————————— ————————————————————————————————————————————————————————————————— The Committee on Health Policy (Brodeur) recommended the following: 1 Senate Amendment to Amendment (100780) (with title 2 amendment) 3 4 Delete lines 610 - 623 5 and insert: 6 (d) Require the pharmacy benefit manager to pass 100 7 percent of all prescription drug manufacturer rebates, including 8 nonresident manufacturer rebates, received to the pharmacy 9 benefits plan or program, if the contractual arrangement 10 delegates the negotiation of rebates to the pharmacy benefit 11 manager, for the sole purpose of offsetting defined cost sharing 12 and reducing premiums of covered persons. Any excess rebate 13 revenue after the pharmacy benefit manager and the pharmacy 14 benefits plan or program have taken all actions required under 15 this paragraph must be used for the sole purpose of offsetting 16 copayments and deductibles of covered persons. This paragraph 17 does not apply to contracts involving Medicaid managed care 18 plans. 19 20 ================= T I T L E A M E N D M E N T ================ 21 And the title is amended as follows: 22 Delete lines 1250 - 1251 23 and insert: 24 pharmacy; specifying requirements for certain